This is a prospective, multi-center, randomized, controlled clinical study, designed to evaluate the safety and effectiveness of the SJM Portico Transcatheter Heart Valve and Delivery Systems (PORTICO) via transfemoral and alternative delivery methods. This trial includes both high-risk and extreme-risk patients.